CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 6 analysts with an average price target of $202.43. This is a potential upside of $194.12 (2335.98%) from yesterday's end of day stock price of $8.31.

Corbus Pharmaceuticals's activity chart (see below) currently has 39 price targets and 41 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.53% with an average time for these price targets to be met of 53.27 days.

Highest price target for CRBP is $53, Lowest price target is $32, average price target is $42.5.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 13-Nov-2025. First documented stock forecast 14-Nov-2016.

Currently out of the existing stock ratings of CRBP, 9 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 08-Sep-2020

$53

$44.69 (537.79%)

1 months 30 days ago
(13-Nov-2025)

1/7 (14.29%)

$41.93 (378.77%)

154

Buy

Since 20-Sep-2024

$32

$23.69 (285.08%)

$74

7 months 22 days ago
(21-May-2025)

0/2 (0%)

$24.59 (331.85%)

Buy

Since 08-Sep-2020

$75

10 months 1 days ago
(11-Mar-2025)

1/1 (100%)

$8.1 (12.11%)

147

Buy

Since 14-Feb-2023

10 months 25 days ago
(18-Feb-2025)

2/5 (40%)

$61.01 (321.27%)

7

Buy

Since 26-Jun-2024

$40

$31.69 (381.35%)

$85

1 years 3 months 23 days ago
(20-Sep-2024)

0/2 (0%)

$20.49 (105.02%)

Show more analysts

Please expand the browser size to see the chart

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 53.27 days on average for the stock forecasts to be realized with a an average price target met ratio 26.53

Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

JAMES EDWARDES JONES

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones works at RBC and has 0 price targets and 0 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with highest potential upside - $953.26

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with lowest potential downside - -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?